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ABSTRACT 
 
Mesoporous silica materials, discovered in 1992 by the Mobile Oil Corporation, 
have received considerable attention in the chemical industry due to their superior textual 
properties such as high surface area, large pore volume, tunable pore diameter, and 
narrow pore size distribution. Among those materials, MCM-41, referred to Mobile 
Composition of Matter NO. 41, contains honeycomb liked porous structure that is the 
most common mesoporous molecular sieve studied. Applications of MCM-41 type 
mesoporous silica material in biomedical field as well as catalytical field have been 
developed and discussed in this thesis.  
The unique features of mesoporous silica nanoparticles were utilized for the design 
of delivery system for multiple biomolecules as described in chapter 2. We loaded 
luciferin into the hexagonal channels of MSN and capped the pore ends with gold 
nanoparticles to prevent premature release. Luciferase was adsorbed onto the outer 
surface of the MSN. Both the MSN and the gold nanoparticles were protected by 
poly-ethylene glycol to minimize nonspecific interaction of luciferase and keep it from 
denaturating. Controlled release of luciferin was triggered within the cells and the 
enzymatic reaction was detected by a luminometer. Further developments by varying 
enzyme/substrate pairs may provide opportunities to control cell behavior and manipulate 
intracellular reactions.  
MSN was also served as a noble metal catalyst support due to its large surface area 
and its stability with active metals. We prepared MSN with pore diameter of 10 nm 
vi 
 
(LP10-MSN) which can facilitate mass transfer. And we successfully synthesized an 
organo silane, 2,2'-Bipyridine-amide-triethoxylsilane (Bpy-amide-TES). Then we were 
able to functionalize LP10-MSN with bipyridinyl group by both post-grafting method and 
co-condensation method. Future research of this material would be platinum 
complexation. This Pt (II) complex catalyst has been reported for a C-H bond activation 
reaction as an alternative of the traditional Friedel-Crafts reaction. And we will compare 
the turnover numbers of MSN supported material with homogenous catalyst to evaluate 
the catalytical efficiency of our material. 
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CHAPTER 1. DISSERTATION ORGANIZATION 
 
The dissertation is organized in four chapters. Chapter 1 describes the organization 
of this dissertation. Chapter 2 is a journal article and will be submitted for publication. 
Chapter 3 is a preliminary study of a collaborating project with researchers from 
University of Virginia. Chapter 4 concludes this dissertation and discusses future work of 
this research. 
Chapter 2 presents a luciferase and luciferin co-delivery system for intracellular 
catalysis reactions. The aim of this chapter is to describe the design of this co-delivery 
system and demonstrate its in vitro application in triggering artificial intracellular 
reactions, converting biological energy into usable forms and controlling cell functions. 
Chapter 3 discusses the synthesis of 2,2'-Bipyridine functionalized large pore 
mesoporous silica nanoparticle. This bipyridinyl group can further coupled with Pt which 
possesses potential use for C-H bond activation reaction. The structure of the material and 
bipyridinyl group loading amount was investigated and reported in this chapter. 
The last chapter is a brief conclusion of this dissertation with general achievements, 
potential applications and future goals. 
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CHAPTER 2. CO-DELIVERY OF ENZYME AND SUBSTRATE 
USING MESOPOROUS SILICA NANOPARTICLES FOR 
INTRACELLULAR CONTROLLED CATALYTIC REACTION 
Xiaoxing Sun, Yannan Zhao, Igor I. Slowing*, Brian G. Trewyn* and Victor S.-Y. Lin† 
Department of Chemistry, U.S. Department of Energy and Ames Laboratory, Iowa State 
University, Ames, Iowa 50011-3111, U.S.A. 
Corresponding authors: e-mails: bgtrewyn@iastate.edu and islowing@iastate.edu; 
telephone: 515-294-8007, 515-294-6220; Fax: 515-294-4709 
ABSTRACT  A surface-modified gold nanoparticle end-capped mesoporous silica 
nanoparticle (MSN) was developed for intracellular co-delivery of enzyme (luciferaase) 
and substrate (luciferin) with retention of bioactivity.  Intracellular controlled catalytic 
reaction was triggered by tuning intracellular reduing environment.  The effectiveness of 
luciferase catalyzed luciferin reaction and luminescence emission in presence of Mg2+ and 
intracellular ATP was measured by luminometer. We envision that this MSN-based 
co-delivery system will provide a new approach for intracellular delivery of multiple 
bioactive molecules to reduce or enhance certain cellular activities, bring new cell 
functions, or convert biological energy (ATP) to usable forms. 
KEYWORDS Mesoporous silica nanoparticle, co-delivery, luciferase, luciferin, ATP, 
intracellular catalysis 
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The intracellular delivery and controlled release of biogenic molecules, such as genes, 
enzymes and proteins, and other molecules of pharmaceutical interest,1, 2 provides a 
powerful tool for therapeutics and fundamental study of biological processes such as 
enzyme-catalyzed reactions.  While significant progress in nanotechnology and drug 
delivery has led to the availability of intracellular delivery of membrane-impermeable 
enzymes,3-5 conducting biochemical or catalytic reactions inside living cells remains 
relatively unexplored.  As a prelude to cellular applications, such as enzyme-catalyzed 
therapeutic activation (ECTA),6 it is desirable to develop a new biocompatible model 
system for intracellular delivery of multiple bioactive molecules to reduce or enhance 
certain cellular activities, bring new cell functions, or convert biological energy (ATP) to 
usable forms.  There are two major challenges confronting the advancement of this field: 
the design of nanomaterials for intracellular controlled release of multiple biogenic 
species with preserved bioactivities and the development of methods for imaging and 
quantification of cellular catalytic reactions. 
Recently, mesoporous silica nanoparticles (MSNs) have been demonstrated as an 
excellent candidate for co-delivery applications,7, 8 owing to the co-existence of both 
interior pore and exterior particle surfaces for loading different guest molecules.  This 
unique feature provides the possibility of using MSN for controlled release and 
co-delivery of enzyme and substrate for intracellular enzymatic reaction.  Although 
many enzyme-catalyzed reactions could be targeted for this purpose, it is difficult to 
measure the dynamic effectiveness of such enzyme-substrate co-delivery systems.  
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Enzymatic catalysis of light emission offers a unique tool for investigating the enzyme 
and substrate activities.9, 10  Luciferase-mediated bioluminescence imaging has served as 
a reporting tool for monitoring various biological processes such as imaging reporter gene 
expression in living subjects.11  The luciferase-catalyzed oxidation of its substrate 
luciferin to oxyluciferin requires the presence of oxygen and Mg2+ ions, and is 
energetically enabled by the presence of ATP, which binds to the luciferase and thereby 
activates the enzyme.9, 10  The bioluminescence emitted in this oxidation reaction is a 
direct measure of the effectiveness of this enzyme-catalyzed reaction.  However, the use 
of luciferase has been limited to the additional injection of luciferin substrate. 
Herein, we report on the synthesis and surface modification of a gold 
nanoparticle-capped MSN material for intracelluar co-delivery of enzyme luciferase and 
its substrate luciferin for intracellular controlled catalytic reaction.  As depicted in 
Figure 1, luciferin is loaded in the mesopores of MSN and encapsulated with 
disulfide-linked gold nanoparticles that physically block luciferin from leaching out.  
Luciferase is physisorbed to the external surface of gold nanoparticle-capped MSN 
through electrostatic interactions.  Luciferin molecules trapped inside the pores are 
released upon triggering by disulfide-reducing antioxidants, the presence of intracellular 
glutathione (GSH) or the introduction of dithiothreitol (DTT).  The released luciferin 
would be converted by co-delivered luciferase to oxyluciferin and emission of photon, 
measurable with luminometer.  
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Figure 1. Schematic representation of mesoporous silica nanoparticles (MSNs) for 
intracellular controlled release of luciferase and luciferin. 
 
We first synthesized a 2-(propyldisulfanyl)ethylamine (0.9 mmol g-1) functionalized 
mesoporous silica nanosphere (linker-MSN) material via a method that we previously 
reported.12, 13  As described in the Supporting Information (SI), the material was 
PEGlyated by grafting 2-[methoxy(polyethylenoxy)-propyl]trimethoxysilane to yield the 
PEGlyated (0.1 mmol g-1) linker-MSN with an average particle diameter of 160 nm and 
an MCM-41-type channel-like mesoporous structure (BJH pore diameter = 2.5 nm) 
(Figure 2a).  
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Figure 2. Transmission electron micrographs of (a) PEGlyated linker-MSN, (b) PEG-Au 
NPs, (c) and (d) luciferin-loaded Au-MSN. 
 
We then functionalized the surface of the gold nanoparticle with a carboxylic 
acid-terminated polyethylene glycol (PEG) linker (shown in Figure 1) through ligand 
exchange reaction14 as detailed in the Supporting Information (SI).  The organically 
derivatized gold nanoparticles (PEG-AuNPs) are negatively charged (ζ-potential at -39.6 
(a) (b) 
(c) (d) 
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mV) in PBS (pH 7.4) with an average particle diameter of 3 nm as determined by the 
transmission electron microscopy (Figure 2b).   
Luciferase activity assays as described in the SI demonstrated that the particle surface 
properties of both MSN and gold nanoparticle play a crucial role in the retention of 
enzyme bioactivity, which is consistent with other literature reports.15  With MSN and 
gold nanoparticle surface PEGlyation, 75% and 63% of luciferase activity of was 
preserved after 2 h incubation at 37 °C, respectively.  In contrast, linker-MSN and 
1-propanethiol-stabilized gold nanoparticles inhibited over 80% of luciferase activity. 
The mesopores of PEGlyated linker-MSN (25 mg) were loaded with luciferin (33 μM) 
in PBS buffer (pH 7.4) and then capped with PEG-Au NPs (25 mg) through amide bond 
formation between the carboxylic acid groups of PEG-Au NP and amino groups of  
PEGlyated linker-MSN (Figure 1), giving rise to the desired luciferin-loaded Au-MSN 
(Figure 2c and d).  The loading of luciferin were determined to be 13.1 μmol g-1 by 
fluorescence emission spectroscopy. 
TEM microscopy was used to confirm the capping of PEG-Au NPs to the pore 
entrances of PEGlyated linker-MSN.  Figure 2 shows the TEM micrographs of 
PEGlyated linker-MSN before and after capping with PEG-AuNPs.  In the case of the 
uncapped MSN (Figure 2a), the hexagonally packed mesoporous channels could be 
clearly visualized.  In contrast, the TEM micrographs of gold nanoparticle-capped MSN 
(Figure 2c and d) show dark spots on MSN surface, representing the attachment of gold 
nanoparticles on the exterior surface of MSN.  
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To determine if release of luciferin from the conjugates could be induced by disulfide 
cleavage as desired for intracellular release, luciferin loaded Au-MSN (1 mg mL-1) was 
suspended in PBS buffer (pH 7.4) for 23 h before addition of 1 mM DTT.  As shown in 
Figure 3a, the Au-MSN drug delivery system exhibited less than 5.0% of drug release in 
PBS buffer over a period of 23 h. The result suggested a good capping efficiency of the 
gold nanoparticles for encapsulation of the luciferin molecules against leaching.  
Addition of disulfide-reducing molecules, DTT (1 mM) triggered a rapid release of the 
mesopore-entrapped luciferin.  Within 10 h, the release reached 100% of the total 
release corresponding to ca. 11% of the total luciferin loading. 
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Figure 3. (a) Controlled release of luciferin from luciferin-loaded Au-MSN (1 mg mL-1) 
triggered by 1 mM dithiothreitol (DTT) at pH 7.4; (b) Observed bioluminescence from 
luciferase-luciferin Au-MSN (1 mg mL-1) as a function of time after addition of 0.1, 0.5 
and 1 mM DTT at pH 7.4. 
(a
(b) 
10 
 
 
The most advantageous feature of the MSN technology is its potential to deliver 
different biogenic species simultaneously in a controlled fashion.  To construct the 
enzyme-substrate co-delivery system, the luciferin-loaded Au-MSN (1 mg mL-1) was 
mixed with luciferase (1 mg mL-1) in PBS buffer (pH 7.4) for 2 h, followed by 
centrifugation and freeze drying to generate the luciferase adsorbed and luciferin loaded 
Au-MSN (luciferase-luciferin Au-MSN).  To examine the applicability of this 
co-delivery system, luciferase activity assays were carried out in a 96-well plate using a 
standard procedure, as described in the SI.  The luminescence intensity remained at 
background level over a period of 60 minutes before the addition of disulfide bond 
reducing agents, suggesting a “zero premature release” property of this system.  After 
addition of DTT (1 mM), luciferin was released and converted to oxyluciferin catalyzed 
by luciferase pre-adsorbed on the external surface of Au-MSN.  As shown in Figure 3b, 
the pattern of luminescence as a function of time was similar for all DTT doses (0.1, 0.5, 
1 and 10 mM).  The highest luminescence signal was detected in 5 minutes and 
gradually decayed, reaching background after approximately 180 min.  The observed 
luminescence strongly depends on the concentration of DTT.  An increase in the 
luminescence signal was observed with increasing DTT dose up to 1 mM, suggesting a 
dose-dependent controlled release profile.  Interestingly, when 10 mM DTT was 
introduced to the system, the luminescence showed a 15% decrease in intensity compared 
to the signal triggered by 1 mM DTT, which can be attributed to the denaturation of 
luciferase by high DTT concentrations. 
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To demonstrate that the enzyme-substrate Au-MSN system can simultaneously delivery 
both the enzyme luciferase and the substrate luciferin for intracellular enzyme-catalyzed 
reaction, luciferase-luciferin Au-MSN (50 μg mL-1) was allowed to be internalized by 
human cervical carcinoma (Hela) cells.  After 3 h incubation, the intracellular 
luciferase-catalyzed luciferin conversion and light emission was initiated by the addition 
of 2 μmol Mg2+.  As shown in Figure 4a, luminescence was generated immediately after 
the injection of Mg2+ and slowly decayed over the next 30 min, whereas almost no signal 
was detected when free solutions of luciferase and luciferin were injected, suggesting the 
capability of this MSN system for co-delivery of enzyme and substrate and controlled 
release of loaded-substrate triggered by intracellular reducing environment.  Upon 
addition of 1 mM DTT following the decay of the intracellular redox-potential triggered 
luminescence, a significant signal is generated within 10 min, followed by a gradual 
decay, consistent with the observation from the ex vivo experiment (Figure 3b). 
To confirm the observed luminescence was due to intracellular release of luciferin and 
its reaction with co-delivered luciferase but not the presence of extracellular ATP arising 
from the material-induced apoptosis, the cell viability was evaluated by Guava ViaCount 
cytometry assay after 24 h incubation with luciferase-luciferin Au-MSN at different 
concentrations (20, 50, 100 μg ml-1).  Over 95% of viable cells were observed when up 
to 100 μg ml-1 of the material was incubated with Hela cells (Figure S6). 
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Figure 4. (a) in vitro bioluminescence intensity of  Hela cells (dot), Hela cells incubated 
with free luciferase and luciferin (cross) and Hela cells incubated with luciferase-luciferin 
Au-MSN (circle).  (b) Controlled intracellular catalytic reaction from Hela cells 
(a) 
(b) 
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incubated with luciferase-luciferin Au-MSN (50 μg mL-1) triggered by 1 mM 
dithiothreitol (DTT) at pH 7.4. 
 
 
 
Figure 5. (a) Fluorescence confocal micrographs of Hela cells internalized with 50 μg 
mL-1 of luciferase-luciferin FITC-Au-MSN (green) for 3 h.  Cell nuclei were stained 
with DAPI(blue).  (b) Corresponding bright field image of Hela cells.  (c) Fluorescence 
confocal and bright field merged image.  (d-f) Transmission electron micrographs of 
Hela cells internalized with 50 μg mL-1 of luciferase-luciferin FITC-Au-MSN for 3 h.  
Images increase in magnification from left to right. 
 
The cellular uptake properties were examined and visualized by confocal fluorescence 
microscopy and transmission electron microscopy (TEM).  MSNs were labeled with 
(d) (e) (f) 
(a) (b) (c) 
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FITC as described in SI to yield fluorescence emission at 520 nm.  Luciferase-luciferin 
FITC-Au-MSN (50 μg mL-1) was incubated with Hela cells for 3 h and was indeed 
internalized by Hela cells as depicted by fluorescence confocal micrographs (Figure 5a-c).  
TEM samples were prepared as described in SI.  TEM images (Figure 5d-f) also 
confirmed the successful endocytosis of luciferase-luciferin Au-MSN. 
The synthesis and performance of this enzyme-substrate Au-MSN co-delivery system 
establishes an operational facile method for intracellular controlled catalytic reaction.  
The effectiveness of the enzyme-catalyzed reaction inside living cells can be tuned by 
varying the intracellular reducing environment.  The luciferase-luciferin Au-MSN 
system was designed to allow imaging and quantification of the intracellular catalysis, 
thereby providing a practical method to evaluate the effectiveness of intracellular enzyme 
and substrate co-delivery.  In addition, it has been recently observed that MSNs are able 
to undergo exocytosis and harvest intracellular molecules.16  These findings suggest that 
MSN could serve not only as vehicles for co-delivering enzyme and substrate into living 
cells but also for sequestering the product out of cells for a variety of biotechnological 
applications. 
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characterization and additional figures.  This material is available free of charge via the 
internet at http://pubs.acs.org. 
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Appendix: Supporting Information 
 
Synthesis of 1-propanethiol stabilized gold nanoparticles.  Following a reported 
procedure1, HAuCl4 (354.4 mg) was dissolved in H2O (30 ml), mixed with a solution 
containing N(C8H17)4Br (2.187 g) and toluene (80 ml).  The two phase mixture was 
vigorously stirred for 20 min and the organic phase was collected, followed by the 
addition of 1-propanethiol (68.5 mg) and NaBH4 solution.  The solution was stirred at 
room temperature for 3 hours and the organic phase was separated.  The solvent was 
removed under reduced pressure and the remaining product was mixed with 400 ml 
ethanol.  The mixture was kept at -18  until dark brown solid precipitated℃ .  Finally, 
the dark brown solid was centrifuged and washed with ethanol several time to afford 
1-propanethiol stabilized gold nanoparticles.  
Synthesis of 2-(2-{2-[2-(2-[2-(11-mercapto-undecyloxy)-ethoxy]-ethoxy)-ethoxy] 
-ethoxy}-ethoxy)-ethoxy-acetic acid (Thiolalkyl-EG6-COOH) stabilized gold 
nanoparticles.  1-propanethiol stabilized gold nanoparticles (20 mg) were dissolved in 
20 ml dichloromethane.  Thiolalkyl-EG6-COOH (474 mg) was dissolved in 
dichloromethane and added into the gold nanoparticles solution.  The mixture was 
stirred at room temperature for 24 hours.  The solid was centrifuged, washed with 
dichloromethane and dried under high vacuum.  
Synthesis of thiol group functionalized mesoporous silica nanoparticle 
(thiol-MSN).  N-Cetyltrimethylammonium bromide (CTAB; 1.00 g) was dissolved in 
480 mL of nanopure water.   NaOH (aq) (2.00 M, 3.50 mL) was introduced to the 
18 
 
CTAB solution at 353 K.  Tetraethoxysilane (TEOS, 5.00 mL, 22.4 mmol) and 
3-mercaptopropyltrimethylsilane (MPTMS, 1.00ml, 5.4 mmol) was dropwisely added to 
the CTAB solution under vigorous stirring.   The mixture was allowed to react for 2 h to 
genrate a white precipitate.   This solid crude product was filtered, washed with 
nanopure water and methanol, and dried under high vacuum to yield the as-synthesized 
thiol-MSN.  
Synthesis of PEG functionalized thiol-MSN.  As-synthesized thiol-MSN (1.00 g) 
was suspended in anhydrous toluene (80 ml), followed by the addition of 
2-[methoxy(polyethylenoxy)-propyl]trimethoxysilane (PEG-silane; 1 mmol).  The 
dispersion was refluxed for 20 hours.  The solid was filtered, washed with toluene and 
methanol and dried under high vacuum.  The surfactant was removed by refluxing the 
material (1.00 g) in 1.0 ml of HCl (37.4%) and 100 ml of methanol for 6 hours.  After 
that, the material was washed extensively with methanol and placed under high vaccum to 
remove remaining solvent.    
Synthesis of PEG functionalized 3-(Propyldisulfanyl)propylamine-MSN 
(PEGlyated linker-MSN).  Surfactant-free PEG functionalized thiol-MSN (0.20 g) and 
2-aldrithiol (0.75 g) was dissolved in ethanol (80 ml).  The mixture was stirred at room 
temperature for 24 hours to undergo the disulfide bond exchange reaction.  The solid 
was collected, washed with ethanol and dried under high vacuum.  The white powder 
was resuspended in 30 ml ethanol, followed by the dropwise addition of aminoethanethiol 
(0.18 g) in 20 ml ethanol solution.  The dispersion was stirred at room temperature for 
19 
 
24 hours.  PEGlyated-linker-MSN was centrifuged, washed with copious ethanol and 
dried under high vacuum.  
Characterization.  XRD patterns of the MSN materials were collected in a Rigaku 
ultima IV X-ray diffractometer using Cu Kα irradiation.  N2 adsorption/desorption 
analysis was measured by nitrogen sorption isotherms in a Micromeritics Tristar 3000 
sorptometer.  The surface areas were calculated by the Brunauer-Emmett-Teller (BET) 
method, and the pore size distribution was calculated by the Barrett-Joyner-Halenda (BJH) 
method.  
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Figure S1: Low angle X-ray diffraction pattern of Thiol-MSN (black) and PEG 
functionalized linker-MSN (red) 
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Figure S2: N2 adsorption/desorption isotherms and pore size distribution of PEGlyated 
linker-MSN 
 
Table S1: BET and BJH parameters 
Material BET surface areaSBET (m2/g) 
BET Pore Volume
VP (cm3/g) 
BJH Pore diameter 
WBJH (Å) 
PEGlyated linker-MSN 929 0.698 25.0 
 
Loading experiment.  Linker-MSN (25.0 mg) was added to 10 ml D-luciferin 
solution (PBS solution; pH 7.4; 35.7 μM) and the mixture was stirred at room temperature 
for 24 hours.  Thiolalkyl-EG6-COOH stabilized gold nanoparticles (25.0 mg) were 
suspended in the same solution along with the addition of N-hydroxysuccinimide (NHS; 
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10 mg) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC; 10 
mg).  The mixture was stirred for another 24 hours before the precipitate was filtered, 
washed several times (>8) with PBS solution and dried under vacuum.  The washing 
solution was also collected and measured with fluorescence microscopy (FluoroMax-2, 
λex: 330 nm, λem: 535 nm).  Loading of luciferin was quantified by the concentration 
difference between original solution and washing solution.  
Releasing experiment.  Luciferin-loaded Au-MSN material (5 mg) was suspended 
in 5 ml PBS solution.  The suspension was stirred at room temperature for 23 hours and 
the amount of luciferin that leaked from the material was quantified by fluorescence 
microscopy (FluoroMax-2, λex: 330 nm, λem: 535 nm).  Then, dithiothreitol (DTT) was 
added and made a final concentration of DTT to be 1 mM.  The mixture was stirred for 
another 23 hours.  Release of luciferin was monitored at different time intervals with 
fluorescence microscopy.  
Loading of luciferase onto MSN.  Luciferin-loaded Au-MSN material (1 mg) was 
added into 1 ml luciferase solution (pH 7.4 PBS; 1 mg/ml).  This mixture was let in 
contact for 2 hours.  Then, luciferase physisorbed MSN was washed three times with 
PBS solution and freeze dried.  
Luciferase activity assay.  Luciferase acitivty was measured by the 
bioluminescence intensity generated from luciferin-ATP reaction.  In our study, 2 μmol 
of MgSO4, 0.02 μmol of ATP and 0.01 μmol of luciferin were mixed.  Pure enzyme or 
luciferase-physisorbed MSN was added to the mixture at different concentrations.  PBS 
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solution was added to make the final volume to be 250 μL.  Luminescence intensity was 
measured by a luminometer of a microplate reader (Synergy MX).  
  
 
Figure S3: (a) Observed bioluminescence intensity from luciferase activity assay using 
pure luciferase (1 mg mL-1) (gray), luciferase (1 mg mL-1) incubated with linker-MSN 
(a) 
(b) 
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(0.5 mg mL-1) (white) and luciferase (1 mg mL-1) incubated with PEGlyated linker-MSN 
(0.5 mg mL-1) (black).   (b) Observed bioluminescence intensity from luciferase activity 
assay using pure luciferase (1 mg mL-1) (gray), luciferase (1 mg mL-1) incubated with Au 
NPs (0.5 mg mL-1) (white) and luciferase (1 mg mL-1) incubated with PEG-Au NPs (0.5 
mg mL-1) (black).  
Cell Viability study of luciferin loaded Au-MSN in Human Cervical Carcinoma 
(Hela) cells.  Hela cells were seeded in 6-well plates at a concentration of 1×105 cells/ml.  
Cells were incubated in D-10 medium (Dubelcco Modified Eagle’s Medium with horse 
serum, L-alanyl-L-glutamine, gentamicin sulfate, and penicillinstreptomycin solution) for 
24 hours at 37 °C in 5% CO2.  After that, D-10 medium was replaced by a suspension of 
luciferin loaded Au-MSN in D-10 medium (20, 50, 100 μg/ml).  Hela cells were 
incubated with this suspension for another 24 hours.  Finally, the cytotoxicity of the 
samples was evaluated by Guava ViaCount cytometry assay (Guava Technologies, Inc.; 
Hayward, CA).   Hela cell viability was calculated as a percentage of viable cells treated 
with luciferin loaded Au-MSN compared to untreated cells (control), as shown in Figure 
S4.    
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Figure S4: Cell viability study of Hela cells incubated with luciferase-luciferin Au-MSN 
at different concentrations.  
 
Luciferin loaded Au-MSN endocytosis study with Hela cells.  Linker-MSN was 
labeled by fluorescein isothiocyanate (FITC) based on our previous reports2.  Hela cells 
at a concentration of 1×105 cells/ml were incubated in 6-well plates with D-10 medium 
for 24 hours at 37 °C in 5% CO2.  D-10 Medium was replaced by a suspension of 
luciferin loaded Au-MSN (50 μg/ml) in serum-free medium at 37 °C in 5% CO2.  At 
different time periods (10 min, 30 min, 60 min, 180 min, 360 min, 540 min), the cells 
were washed with PBS, trypsinized and centrifuged.  The pellets were incubated with 
830 mM tryphan blue before flow cytometry analysis (BD FACSCanto instrument).  An 
aliquot of sample was mounted between plastic coverslips and imaged in a Leica SP5 X 
confocal system.  
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Figure S5: Endocytosis kinetics measurement of Hela cells incubated with 
luciferase-luciferin Au-MSN (50 μg/ml) 
 
Confocal fluorescence microscopy.  Coverslips (22 mm2) were cleaned with 1.0 
M HCl, nanopure water (3×), 50% ethanol, 70% ethanol, and 100% ethanol, and dried 
overnight at 60 °C.  Cleaned coverslips were placed on the bottom of the wells of 6-well 
plates.  Hela cells at a concentration of 1×105 cells/ml were incubated in coverslips 
contained 6-well plates with D-10 medium at 37 °C in 5% CO2.  After 24 hours, medium 
was replaced by a suspension of luciferin loaded Au-MSN (50 μg/ml) in serum-free 
medium.  Hela cells were incubated for 3 hours.  Following that, medium was removed, 
and the cells were washed with PBS (2×) and incubated for 30 min with a PBS solution of 
3.7% formaldehyde and 57.0 mM 4,6-Diamidino-2-phenylindole dihydrochloride (DAPI).   
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Coverslips were then taken out from the PBS solution and fixed to glass slides.  
Confocal fluorescence images were obtained by a Leica SP5 X confocal system.  
Transmission Electron Microscopy (TEM) of Hela cell incubated with 
luciferase-luciferin Au-MSN.  Hela cells were prepared as above and incubated with 
material suspension (50 μg/ml in D-10 medium) for 3 hours.  The cells were then fixed 
by adding a 1% glutaraldehyde solution dropwise over 5 min and further incubated at 37 
°C for 1.5 h.  Samples were post-fixed with 1% osmium tetroxide in PBS for 1.5 h.  
Cells were dehydrated in increasing concentrations of ethanol (50%, 60% 70%, 80%, 
90%, and 100%) for 15 min each and stained with 2% uranyl acetate in 70% ethanol at 
room temperature overnight.  The cells were washed three times with acetone and 
embedded in Epon.  Embedded samples were sectioned in 60 nm thick slices on a 
sliding ultramicrotome.  Thin sections supported on copper grids were examined with a 
Tecnai G2 F20 transmission electron microscope operated at 200 kV.  
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CHAPTER 3. FUNCTIONALIZED MESOPOROUS SILICA 
NANOPARTICLE BASED HETEROGENEOUS CATALYST 
FOR C-H BOND ACTIVATION REACTION 
Xiaoxing Sun, Hung-ting Chen, Brian G. Trewyn* and Victor S.-Y. Lin† 
Department of Chemistry, U.S. Department of Energy and Ames Laboratory, Iowa State 
University, Ames, Iowa 50011-3111, U.S.A. 
 
Introduction 
The production of ethylbenzene and related alkyl arenes is important in detergent 
and polymer industries, typically through traditional approaches such as Friedel-Crafts, 
Heck, Suzuki, Sonogashira reactions.1-3 However, significant drawbacks are present. For 
example, high energy input requirement and large waste generation. To overcome these 
drawbacks, an alternative method was developed using Pt (II) complexs for the C-H 
bonds activation4-6. The reaction was based on a Pt-mediated C-H activation pathway 
with relatively high turnover numbers rather than a traditional Friedel-Crafts pathway.  
Silica was widely used as a heterogeneous catalyst support because it is inert to 
active metals. And mesoporous silica nanoparticle has demonstrated its excellence due to 
the follwing two reasons: large surface area, which provides a high loading of active sites, 
and the tunable pore diameter and relatively large pore volume, which facilitates mass 
transfer7-10. Here we developed a synthetic method of mesoporous silica nanoparticles 
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with diameter of 10 nm (LP10-MSN). The large pore diameter and spacious pore volume 
offer an excellent nano-space to accommodate the bulky Pt complexs, whose size is 
around 1-2 nm, as determined by X-ray crystallographic structure.  
 
Experimental Method 
Synthesis of Organosilanes: Here we investigated on the synthesis of an organo 
silane, 2,2'-Bipyridine-amide-triethoxylsilane (Bpy-amide-TES). The structures are 
shown in Figure 1. 2,2'-Bipyridine-amide-triethoxylsilane was synthesized according to a 
modified method reported by Chen11 as depicted in Figure 2. The di-acid was suspended 
in thionyl chloride and refluxed under Ar until complete dissolution of di-acid (about 20 
h).  The excess of SOCl2 was removed by distillation to yield crude acid chloride.  The 
resulting acid chloride was dissolved in CH2Cl2 and was added dropwisely into a CH2Cl2 
solution of 3-aminopropyltrimethoxysilane and NEt3.  The solution became pink color 
and smoke was generated due to neutralization.  After addition, the mixture was stirred at 
room temperature for one hour and the refluxed for another hour.  The solution was 
washed by water twice and brine once.  The organic layer was dried with MgSO4 and 
concentrated under the vacuum to yield light pink white powder. Bpy-amide-TES was 
immobilized onto silica support by both post-grafting method and co-condensation 
method. 
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Figure 1. Structure of 2,2'-Bipyridine-amide-triethoxylsilane (Bpy-amide-TES) 
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Figure 2. Reaction scheme of Bpy-amide-TES synthesis 
 
Post-grafting Method: In the first strategy, unfunctionalized LP10-MSN was 
synthesized based on a previous method12. In brief, the tetramethoxysilane (TMOS) was 
stirred in the 1.6 M HCl solution at 56 °C using PEO-PPO-PEO triblock copolymer (P104) 
as surfactant for 24 hours. The mixture was transferred into a high-pressure reactor for 
aging at 150 °C for another 24 hours. The resulting as-made LP10-MSN was filtered, 
washed with copious amount of water and methanol, and dried under vacuum. The P104 
was removed by calcination at 600 °C for 6 h to yield non-functionalized LP10-MSN 
materials. Varieties of organic groups for anchoring organometallics can be immobilized 
onto LP10-MSN by a post-grafting method. Typically, the surfactant-free LP10-MSN was 
dried at 110 °C under vacuum for 4 h to remove adsorbed moisture. After cooling down to 
room temperature, Bpy-amide-TES in the toluene solution was charged to the LP10-MSN. 
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The mixture was refluxed for 20 h, followed by filtration, washing, and dried under 
vacuum to obtain functionalized LP10-MSNs. This post-grafting method significantly 
maintained the well ordered 2D hexagonal mesopore structures.  
Co-condensation Method: In the second approach, a co-condensation method was 
applied, which results in a homogeneous distribution of organometallics. Triblock 
copolymer P104 was stirred in the 1.6 M HCl solution at 56 °C for 30 minutes to allow 
full dissolution. TMOS was added and stirred with the above solution at 56 °C for 30 
minutes and white precipitate was generated. Bpy-amide-TES in hot ethanol solution was 
stirred with the mixture for 24 hours. Similar to the synthesis of unfunctionalized 
LP10-MSN, the mixture was transferred into a high-pressure reactor for aging at 150 °C 
for another 24 hours. The resulting as-made bipyridinyl-functionalized LP10-MSN was 
filtered, washed with copious amount of water and methanol, and dried under vacuum. 
The P104 was removed by refluxing in ethanol for 24 hours to yield 
bipyridinyl-functionalized LP10-MSN materials. 
 
Results and Discussion 
To investigate the material structures, powder X-ray diffraction (XRD) tests and N2 
adsorption/desorption analysis were performed. XRD patterns of the MSN materials were 
collected in a Rigaku ultima IV X-ray diffractometer using Cu Kα irradiation (Figure 3). 
Both bipyridinyl group functionalized LP10-MSN materials (post-grafting method and 
co-condensation method) exhibited the typical diffraction patterns of SBA-15 type 
mesoporous silica with highly ordered MSN parallel structures and hexagonal symmetry. 
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N2 adsorption/desorption analysis was measured by nitrogen sorption isotherms in a 
Micromeritics Tristar 3000 sorptometer (Figure 4). The surface areas were calculated by 
the Brunauer-Emmett-Teller (BET) method, and the pore size distribution was calculated 
by the Barrett-Joyner-Halenda (BJH) method, as detailed in Table 1.  
 
Figure 3. Low angle X-ray diffraction pattern of Bpy-admie-TES grafted LP10-MSN (red) and 
Bpy-amide-TES cocondensed LP10-MSN (black). 
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Figure 4. (a) N2 adsorption/desorption isotherms of Bpy-admie-TES grafted LP10-MSN (blue 
triangle) and Bpy-amide-TES cocondensed LP10-MSN (red dot). (b) Pore size distribution of 
Bpy-admie-TES grafted LP10-MSN (blue dot) and Bpy-amide-TES cocondensed LP10-MSN (red 
triangle). 
(a) 
(b) 
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Table S1: BET and BJH parameters 
Material BET surface areaSBET (m2/g) 
BET Pore Volume
VP (cm3/g) 
BJH Pore 
diameter 
WBJH (Å) 
Bpy-admie-TES grafted 
LP10-MSN 
578 0.79 5.4 
Bpy-amide-TES 
cocondensed 
LP10-MSN 
407 0.63 5.8 
 
To study the morphology of the material, particle was studied with a JEOL 840A 
scanning electron microscope with a 10 kV acceleration voltage, depicted in Figure 5. 
Morphology of Bpy-amide-TES grafted LP10-MSN, showing a well-ordered hexagonal 
disk-like shape, is consistent with the XRD result. However, morphology of 
Bpy-amide-TES cocondensed LP10-MSN revealed a football-like shape with each 
particle head-to-tail connected.   
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Figure 5. Scan electron microscopy images of Bpy-admie-TES grafted LP10-MSN (a, b) 
and Bpy-amide-TES cocondensed LP10-MSN (c, d).  Images increase in magnification 
from left to right. 
 
The distribution and loading amount of bipyridinyl groups was measured by 29Si 
direct polarization (DP) solid-state NMR spectroscopy, shown in Figure 6. 
Bpy-amide-TES co-condensed LP10-MSN had a loading of 0.46 mmol/g and showed 
normal loading with T2 and T3 sites. Bpy-amide-TES grafted sample had a loading of 
0.44 mmol/g. However, it exhibited different behavior with a large amount of T1 sites, as 
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well as the presence of T0, T2 and T3 peaks. The small amount of T0 sites imply that a few 
of the groups have only one linker attached to the silica surface, while the other linker is 
"floating". The high presence of the T1 sites could be due to the bulky nature of the group, 
allowing the group to site farther from the surface.  
 
 
Figure 6. 29Si solid state NMR spectra of (a) Bpy-admie-TES grafted LP10-MSN and (b) 
Bpy-amide-TES cocondensed LP10-MSN. 
(b) 
(a) 
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Conclusion 
We have successfully immobilized Bpy-amide-TES onto LP10-MSN by both 
post-grafting method and co-condensation method. This material we have synthesized 
would obtain further interest in complexation with platinum for the C-H bond activation 
reaction, for example, ethylene/benzene reaction, with relatively high turnover numbers. 
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CHAPTER 4. GENERAL CONCLUSIONS 
  
Applications of mesoporous silica nanoparticles (MSN) have been extensively 
developed since the discovery of mesoporous materials. Unique features of MSN, such as 
large surface area, tunable pore diameter, controlled particle size and morphology, 
excellent biocompatibility, offer great advantage. Contributions in both biomedical field 
and catalytical field have been made in Dr. Lin’s and Dr. Trewyn’s group, using MSN to 
serve either as a multi-biomolecules intracellular delivery vehicle with preserved 
bioactivity or as support for noble metal catalyst complexation. 
As a biomolecule intracellular delivery vehicle, MSN was functionalized with 
poly-ethylene glycol to prevent nonspecific interaction between silica surface and 
biomolecules and to preserve their bioactivity. The presence of both mesopore channels 
and outer particle surface provides the possibility to delivery several biomolecules 
simultaneously. So that biomolecules are guaranteed to be delivered to the same spot. 
Moreover, the pore openings were capped with gold nanoparticles so that the release of 
biomolecules that was loaded inside mesopores can be trigger controlled, either by 
internal stimuli (intracellular environment) or by external stimuli (dithiothreitol) by the 
intracellular environment itself, to manipulate the delivery with accurate control of site 
and timing. We also demonstrated an in vitro luciferase catalyzed light generating reaction 
of luciferin into oxyluciferin with the help of intracellular ATP. This system makes the 
co-delivery of an enzyme and its substrate possible so that we may artificially control 
intracellular reactions or manipulate cells to generate desired molecules in the future.  
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As a support for noble metal catalyst, LP10-MSN was utilized for its enhanced 
mass-transfer efficiency. Bipyridinyl silane was successfully synthesized and immobilized 
onto LP10-MSN by two conventional method, post-grafting and co-condensation. 
Hexagonal mesopore structure was retained after bipyridinyl functionalization. This 
material would obtain further interest in complexation with platinum for the C-H bond 
activation reaction, for example, ethylene/benzene reaction, with relatively high turnover 
numbers.  
The research presented in this dissertation opens the door for the design of series of 
novel biomolecules co-delivery systems as well as the development of the existing noble 
metal catalyst. However, applications of MSN are not limited to what has been discussed 
here. Further work, such as in vivo application, still needs to be investigated.   
    
 
 
